Opus Genetics (IRD)
NASDAQ:IRD
Holding IRD?
Track your performance easily

Opus Genetics (IRD) Income Statement

989 Followers

Opus Genetics Income Statement

Last quarter (Q2 2024), Opus Genetics's total revenue was $1.11M, a decrease of -69.73% from the same quarter last year. In Q2, Opus Genetics's net income was $-7.76M. See Opus Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 16.45M$ 19.05M$ 39.85M$ 589.00K$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 16.45M$ 19.05M$ 39.85M$ 589.00K--
Operating Expense
$ 31.53M$ 29.61M$ 21.62M$ -23.29M$ 9.47M$ 4.19M
Operating Income
$ -15.08M$ -10.56M$ 18.23M$ -22.70M$ -9.47M$ -4.19M
Net Non Operating Interest Income Expense
-$ 1.33M$ -9.00K$ -2.00K$ -6.85M$ -1.41M
Other Income Expense
$ -2.31M$ 1.92M$ 14.00K$ 33.99M$ -8.31M$ -567.00K
Pretax Income
$ -14.09M$ -9.97M$ 18.20M$ -56.69M$ -24.62M$ -6.17M
Tax Provision
$ 12.00K$ 12.00K$ 315.00K-$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -12.78M$ -9.99M$ 17.89M$ -56.69M$ -24.62M$ -6.17M
Basic EPS
$ -0.54$ -0.46$ 0.90$ -3.82$ -5.28$ -0.87
Diluted EPS
$ -0.56$ -0.46$ 0.87$ -3.82$ -5.28$ -0.87
Basic Average Shares
$ 94.81M$ 21.59M$ 19.93M$ 14.85M$ 4.66M$ 7.09M
Diluted Average Shares
$ 94.81M$ 21.59M$ 20.60M$ 14.85M$ 4.66M$ 7.09M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 31.53M$ 29.61M$ 21.62M$ -23.29M$ 9.47M$ 4.19M
Net Income From Continuing And Discontinued Operation
$ -14.11M$ -9.99M$ 17.89M$ -56.69M$ -24.62M$ -6.17M
Normalized Income
$ -15.12M$ -7.88M$ 14.38M-$ -16.30M$ -5.67M
Interest Expense
----$ 6.85M$ 1.41M
EBIT
$ -14.09M$ -9.97M$ 18.21M$ -56.69M$ -17.77M$ -4.76M
EBITDA
$ -14.09M$ -9.97M$ 18.22M$ -56.69M$ -17.77M$ -4.76M
Currency in USD

Opus Genetics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis